Marshall Wace North America’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $368K | Buy |
+60,215
| New | +$368K | ﹤0.01% | 1145 |
|
|
2021
Q2 | – | Sell |
-19,262
| Closed | -$172K | – | 1938 |
|
|
2021
Q1 | $172K | Buy |
+19,262
| New | +$172K | ﹤0.01% | 1386 |
|
|
2020
Q4 | – | Sell |
-97,531
| Closed | -$1.02M | – | 1699 |
|
|
2020
Q3 | $1.02M | Sell |
97,531
-79,613
| -45% | -$829K | 0.01% | 800 |
|
|
2020
Q2 | $2.33M | Buy |
+177,144
| New | +$2.33M | 0.02% | 549 |
|
|
2019
Q1 | – | Sell |
-5,610
| Closed | -$64K | – | 2031 |
|
|
2018
Q4 | $64K | Buy |
+5,610
| New | +$64K | ﹤0.01% | 1190 |
|